- Home
- TCBS vs ACHL Comparison
TCBS vs ACHL Comparison
Compare TCBS & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBS
- ACHL
- Stock Information
- Founded
- TCBS 1934
- ACHL 2016
- Country
- TCBS United States
- ACHL United Kingdom
- Employees
- TCBS N/A
- ACHL N/A
- Industry
- TCBS Banks
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TCBS Finance
- ACHL Health Care
- Exchange
- TCBS Nasdaq
- ACHL Nasdaq
- Market Cap
- TCBS 47.0M
- ACHL 46.8M
- IPO Year
- TCBS N/A
- ACHL 2021
- Fundamental
- Price
- TCBS $15.34
- ACHL $1.14
- Analyst Decision
- TCBS
- ACHL Buy
- Analyst Count
- TCBS 0
- ACHL 2
- Target Price
- TCBS N/A
- ACHL $4.00
- AVG Volume (30 Days)
- TCBS 4.0K
- ACHL 266.7K
- Earning Date
- TCBS 02-20-2025
- ACHL 11-14-2024
- Dividend Yield
- TCBS 1.04%
- ACHL N/A
- EPS Growth
- TCBS N/A
- ACHL N/A
- EPS
- TCBS N/A
- ACHL N/A
- Revenue
- TCBS $9,858,000.00
- ACHL N/A
- Revenue This Year
- TCBS N/A
- ACHL N/A
- Revenue Next Year
- TCBS N/A
- ACHL N/A
- P/E Ratio
- TCBS N/A
- ACHL N/A
- Revenue Growth
- TCBS N/A
- ACHL N/A
- 52 Week Low
- TCBS $13.11
- ACHL $0.63
- 52 Week High
- TCBS $15.63
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- TCBS 59.62
- ACHL 55.79
- Support Level
- TCBS $15.00
- ACHL $1.12
- Resistance Level
- TCBS $15.59
- ACHL $1.18
- Average True Range (ATR)
- TCBS 0.31
- ACHL 0.05
- MACD
- TCBS 0.00
- ACHL -0.00
- Stochastic Oscillator
- TCBS 53.97
- ACHL 33.33
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.